Research Original Research| Volume 110, ISSUE 2, P205-214, February 2010

Download started.


Whole-Grain Ready-to-Eat Oat Cereal, as Part of a Dietary Program for Weight Loss, Reduces Low-Density Lipoprotein Cholesterol in Adults with Overweight and Obesity More than a Dietary Program Including Low-Fiber Control Foods



      Weight loss and consumption of viscous fibers both lower low-density lipoprotein (LDL) cholesterol levels. We evaluated whether or not a whole-grain, ready-to-eat (RTE) oat cereal containing viscous fiber, as part of a dietary program for weight loss, lowers LDL cholesterol levels and improves other cardiovascular disease risk markers more than a dietary program alone.


      Randomized, parallel-arm, controlled trial.


      Free-living, overweight and obese adults (N=204, body mass index 25 to 45) with baseline LDL cholesterol levels 130 to 200 mg/dL (3.4 to 5.2 mmol/L) were randomized; 144 were included in the main analysis of participants who completed the trial without significant protocol violations.


      Two portions per day of whole-grain RTE oat cereal (3 g/day oat b-glucan) or energy-matched low-fiber foods (control), as part of a reduced energy (∼500 kcal/day deficit) dietary program that encouraged limiting consumption of foods high in energy and fat, portion control, and regular physical activity.

      Main outcome measures

      Fasting lipoprotein levels, waist circumference, triceps skinfold thickness, and body weight were measured at baseline and weeks 4, 8, 10, and 12.


      LDL cholesterol level was reduced significantly more with whole-grain RTE oat cereal vs control (−8.7±1.0 vs −4.3±1.1%, P=0.005). Total cholesterol (−5.4±0.8 vs −2.9±0.9%, P=0.038) and non–high-density lipoprotein-cholesterol (−6.3±1.0 vs −3.3±1.1%, P=0.046) were also lowered significantly more with whole-grain RTE oat cereal, whereas high-density lipoprotein and triglyceride responses did not differ between groups. Weight loss was not different between groups (−2.2±0.3 vs −1.7±0.3 kg, P=0.325), but waist circumference decreased more (−3.3±0.4 vs −1.9±0.4 cm, P=0.012) with whole-grain RTE oat cereal. Larger reductions in LDL, total, and non–high-density lipoprotein cholesterol levels and waist circumference were evident as early as week 4 in the whole-grain RTE oat cereal group.


      Consumption of a whole-grain RTE oat cereal as part of a dietary program for weight loss had favorable effects on fasting lipid levels and waist circumference.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Academy of Nutrition and Dietetics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hu F.B.
        • Willett W.C.
        Optimal diets for prevention of coronary heart disease.
        JAMA. 2002; 288: 2569-2578
        • National Cholesterol Education Program Expert Panel
        Detection, evaluation, and treatment of high cholesterol in adults (Adult Treatment Panel III). Final report.
        (Accessed October 31, 2009)
        • Dattilo A.M.
        • Kris-Etherton P.M.
        Effects of weight reduction on blood lipids and lipoproteins: A meta-analysis.
        Am J Clin Nutr. 1992; 56: 320-328
        • Brown L.
        • Rosner B.
        • Willett W.W.
        • Sacks F.M.
        Cholesterol-lowering effects of dietary fiber: A meta-analysis.
        Am J Clin Nutr. 1999; 69: 30-42
        • Ripsin C.M.
        • Keenan J.M.
        • Jacobs Jr, D.R.
        • Elmer P.J.
        • Welch R.R.
        • Van Horn L.
        • Liu K.
        • Turnbull W.H.
        • Thye F.W.
        • Kestin M.
        Oat products and lipid lowering.
        JAMA. 1992; 267: 3317-3325
        • Marlett J.A.
        • Hosig K.B.
        • Vollendorf N.W.
        • Shinnick F.L.
        • Haack V.S.
        • Story J.A.
        Mechanism of serum cholesterol reduction by oat bran.
        Hepatol. 1994; 20: 1450-1457
        • Jenkins D.J.
        • Kendall C.W.
        • Faulkner D.A.
        • Nguyen T.
        • Kemp T.
        • Marchie A.
        • Wong J.M.
        • deSouza R.
        • Emam A.
        • Vidgen E.
        • Trautwein E.A.
        • Lapsley K.G.
        • Holmes C.
        • Josse R.G.
        • Leiter L.A.
        • Connelly P.W.
        • Singer W.
        Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia.
        Am J Clin Nutr. 2006; 83: 582-591
        • Mifflin M.D.
        • St Jeor S.T.
        • Hill L.A.
        • Scott B.J.
        • Daughtery S.A.
        • Koh Y.O.
        A new predictive equation for resting energy expenditure in healthy individuals.
        Am J Clin Nutr. 1990; 51: 241-247
        • Haskell W.
        • Lee I.-M.
        • Pate R.P.
        • Powell K.
        • Blair S.N.
        • Franklin B.A.
        • Macera C.A.
        • Heath G.W.
        • Thompson P.D.
        • Bauman A.
        Physical activity and public health: Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association.
        Med Sci Sports Exerc. 2007; 39: 1423-1434
        • Sallis J.F.
        • Haskell W.L.
        • Wood P.D.
        • Fortmann S.P.
        • Rogers T.
        • Blair S.N.
        • Paffenbarger Jr, R.S.
        Physical activity assessment methodology in the Five-City Project.
        Am J Epidemiol. 1985; 121: 91-106
        • Heyward V.
        Designs for Fitness.
        Macmillan Publishing Company, New York, NY1984
        • Friedewald W.T.
        • Levy R.I.
        • Fredrickson D.S.
        Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
        Clin Chem. 1972; 18: 499-502
        • Saltzman E.
        • Krupa Das S.
        • Lictenstein A.H.
        • Dallal G.E.
        • Corrales A.
        • Schaefer E.J.
        • Greenberg A.S.
        • Roberts S.B.
        An oat-containing hypocaloric diet reduces systolic blood pressure and improves lipid profile beyond effects of weight loss in men and women.
        J Nutr. 2001; 131: 1465-1470
        • Karmally W.
        • Montez M.G.
        • Palmas W.
        • Martinez W.
        • Branstetter A.
        • Ramakrishnan R.
        Cholesterol-lowering benefits of oat-containing cereal in Hispanic americans.
        J Am Diet Assoc. 2005; 105: 967-970
        • Johnston L.
        • Reiss-Reynolds H.
        • Patz M.
        • Hunninghake D.B.
        • Schultz K.
        • Westereng B.
        Cholesterol-lowering benefits of a whole-grain oat ready-to-eat cereal.
        Nutr Clin Care. 1998; 1: 6-12
        • Anderson J.W.
        • Spencer D.B.
        • Hamilton C.C.
        • Smith S.F.
        • Tietyen J.
        • Bryant C.A.
        • Oeltgen P.
        Oat-bran cereal lowers serum total and LDL cholesterol in hypercholesterolemic men.
        Am J Clin Nutr. 1990; 52: 495-499
        • Brown B.G.
        • Stukovsky K.H.
        • Zhao X.Q.
        Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: A meta-analysis of 23 randomized lipid trials.
        Curr Opin Lipidol. 2006; 17: 631-636
        • Cohen J.C.
        • Boerwinkle E.
        • Mosley Jr, T.H.
        • Hobbs H.H.
        Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
        N Engl J Med. 2006; 354: 1264-1272
        • Hunninghake D.B.
        • Miller V.T.
        • LaRosa J.C.
        • Kinosian B.
        • Jacobson T.
        • Brown V.
        • Howard W.J.
        • Edelman D.A.
        • O'Connor R.R.
        Long-term treatment of hypercholesterolemia with dietary fiber.
        Am J Med. 1994; 97: 504-508
        • Anderson J.W.
        • Davidson M.H.
        • Blonde L.
        • Brown W.V.
        • Howard W.J.
        • Ginsberg H.
        • Allgood L.D.
        • Weingand K.W.
        Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia.
        Am J Clin Nutr. 2000; 71: 1433-1448
        • Davidson M.H.
        • Maki K.C.
        • Kong J.C.
        • Dugan L.D.
        • Torri S.A.
        • Hall H.A.
        • Drennan K.B.
        • Anderson S.M.
        • Fulgoni V.L.
        • Saldanha L.G.
        • Olson B.H.
        Long-term effects of consuming foods containing psyllium seed husk on serum lipids in subjects with hypercholesterolemia.
        Am J Clin Nutr. 1998; 67: 367-376
        • Després J.P.
        Intra-abdominal obesity: An untreated risk factor for type 2 diabetes and cardiovascular disease.
        J Endocrinol Invest. 2006; 29: 77-82
        • Good C.K.
        • Holschuh N.
        • Albertson A.M.
        • Eldridge A.L.
        Whole grain consumption and body mass index in adult women: An analysis of NHANES 1999-2000 and the USDA pyramid servings database.
        J Am Coll Nutr. 2008; 27: 80-87
        • Newby P.K.
        • Maras J.
        • Bakun P.
        • Muller D.
        • Ferrucci L.
        • Tucker K.L.
        Intake of whole grains, refined grains, and cereal fiber measured with 7-d diet records and associations with risk factors for chronic disease.
        Am J Clin Nutr. 2007; 86: 1745-1753
        • Williams P.G.
        • Grafenauer S.J.
        • O'Shea J.E.
        Cereal grains, legumes, and weight management: A comprehensive review of the scientific evidence.
        Nutr Rev. 2008; 66: 171-182
        • Katcher H.I.
        • Legro R.S.
        • Kunselman A.R.
        • Gillies P.J.
        • Demers L.M.
        • Bagshaw D.M.
        • Kris-Etherton P.M.
        The effects of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome.
        Am J Clin Nutr. 2008; 87: 79-90
        • Institute of Medicine, Food and Nutrition Board
        Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids.
        National Academies Press, Washington, DC2005
        • Behall K.M.
        • Scholfield D.J.
        • Hallfrisch J.
        Whole-grain diets reduce blood pressure in mildly hypercholesterolemic men and women.
        J Am Diet Assoc. 2006; 106: 1445-1449
        • Maki K.C.
        • Galant R.
        • Samuel P.
        • Tesser J.
        • Witchger M.S.
        • Ribaya-Mercado J.D.
        • Blumberg J.B.
        • Geohas J.
        Effects of consuming foods containing oat beta-glucan on blood pressure, carbohydrate metabolism and biomarkers of oxidative stress in men and women with elevated blood pressure.
        Eur J Clin Nutr. 2007; 61: 786-795
        • Davy B.M.
        • Melby C.L.
        • Beske S.D.
        • Ho R.C.
        • Davrath L.R.
        • Davy K.P.
        Oat consumption does not affect resting casual and ambulatory 24-h arterial blood pressure in men with high-normal blood pressure to stage I hypertension.
        J Nutr. 2002; 132: 394-398
        • Keenan J.M.
        • Pins J.J.
        • Frazel C.
        • Moran A.
        • Turnquist L.
        Oat ingestion reduces systolic and diastolic blood pressure in patients with mild or borderline hypertension: A pilot trial.
        J Fam Pract. 2002; 51: 369
        • Kelley G.A.
        • Kelley K.S.
        • Vu Tran Z.
        Aerobic exercise, lipids, and lipoproteins in overweight and obese adults: A meta-analysis of randomized controlled trials.
        In J Obes. 2005; 29: 881-893


      K. C. Maki is chief science officer, Provident Clinical Research, Glen Ellyn, IL, and Bloomington, IN.


      M. S. Reeves is medical director, Provident Clinical Research, Glen Ellyn, IL, and Bloomington, IN.


      V. N. Kaden is a project manager, Provident Clinical Research, Glen Ellyn, IL, and Bloomington, IN.


      T. M. Rains is director of medical writing, Provident Clinical Research, Glen Ellyn, IL, and Bloomington, IN.


      J. M. Beiseigel is a senior scientist, General Mills, Minneapolis, MN.


      C. K. Gugger is a senior scientist, General Mills, Minneapolis, MN.


      S. S. Jonnalagadda is a principal scientist, General Mills, Minneapolis, MN.


      M. V. Farmer is a principal investigator, Meridien Research, St Petersburg, FL.